Download CME Post-Test and Evaluation - Office of Continuing Medical

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Study 329 wikipedia , lookup

Postpartum depression wikipedia , lookup

Behavioral theories of depression wikipedia , lookup

Controversy surrounding psychiatry wikipedia , lookup

Mania wikipedia , lookup

Major depressive disorder wikipedia , lookup

Epigenetics of depression wikipedia , lookup

Biology of depression wikipedia , lookup

Antidepressant wikipedia , lookup

Depression in childhood and adolescence wikipedia , lookup

Transcript
Psychopharmacology for the Primary Care Provider
Part 3: Diagnosis and Treatment of Depression in Children and Adolescents
CME Post-Test and Evaluation
Release Date: March 2009 * Expiration Date: August 31, 2011 *
There is no fee to participate in this activity. To obtain credit, fax the completed post-test and evaluation to Monica Trevino at 210-567-5677 by
August 31, 2011. Credit will only be given if the form is completed and the post-test score is 70% or higher. Please circle the best choice.
1.
2.
3.
The following is true regarding the quality of irritability in mania in children:
A.
It is often occult, and not easily observed by adults.
B.
The irritability is severe and often associated with rages.
C.
It is always associated with classic delusions of grandeur (i.e., believing to be President, etc.)
D.
Pediatric mania is always of the euphoric quality, irritability is solely a symptoms of oppositional defiant disorder (ODD)
Which of the following is true regarding the risk of suicidal ideation with antidepressants in children and adolescents?
A.
Controlled trials, when averaged, show that about 4% of children with depression treated with antidepressants will experience suicidal
ideation compared to 2% of those treated with placebo.
B.
There were multiple completed suicides in the clinical trials of antidepressants in children and adolescents.
C.
Since antidepressants are no better than placebo in treating depression in children and adolescents, they should be avoided at all costs.
D.
The FDA warning about suicidal ideation applies only to serotonin reuptake inhibitors like Prozac.
A 15 year old girl reports a 6 month history of depression that began when she broke up with her boyfriend. She is sad at least 6
hours a day, nearly every day, has lost weight, feels slowed down, and has occasional wishes to be dead. She denies active suicidal
intent. She has seen the therapist 6 times with minimal improvement. The best course for the PCP would be:
A.
Recommend she have therapy for at least another 3 months before attempting medication treatment.
B.
Refer to psychiatry for antidepressant treatment.
C.
Begin fluoxetine 10 mg in the morning, continue psychotherapy and see the PCP within 2 weeks for follow up.
D.
Tell the family antidepressants will not be helpful because there is a psychological stressor causing the depression.
Please Print
CME Evaluation
Name ________________________________________________________
1. Rate the extent to which this educational activity met the identified
educational needs…
Degree _______________________ Specialty _______________________
a. In terms of your satisfaction
□ Excellent
□ Somewhat
□ Not at All
Address _____________________________________________________
____________________________________________________________
City __________________________ State __________Zip_____________
b. In terms of your knowledge enhancement
□ Excellent
□ Somewhat
□ Not at All
c. In terms of your skill enhancement
□ Excellent
□ Somewhat
□ Not at All
Phone________________________ Fax ___________________________
Email _______________________________________________________
2. What changes will you make to your practice as a result of participating in
this presentation?
______________________________________________________________
Signature ___________________________________________________
______________________________________________________________
______________________________________________________________
CME CREDIT
The UT Health Science Center at San Antonio School of Medicine is
accredited by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
3. What barriers exist that will prevent you from making changes to your
practice?
______________________________________________________________
______________________________________________________________
The UT Health Science Center at San Antonio School of Medicine
designates this educational activity for a maximum of 1 AMA PRA
Category 1 CreditTM. Physicians should only claim credit commensurate
with the extent of their participation in the activity.
AMA PRA Category 1 Credit – please indicate the amount of time you
spent on this presentation
_____ hours _____ minutes
Are you willing to participate in an outcomes survey  Yes  No
______________________________________________________________
4. Did you find the information in this presentation to be objective, balanced
and free of commercial bias?
□ Yes
□ No
Comments:
______________________________________________________________
______________________________________________________________
______________________________________________________________